Combination of a cyclo–oxygenase–2 inhibitor and a proton–pump inhibitor for the prevention of recurrent ulzer bleeding in patients at very high risk: a double blind randomized trial. - Chan,FKL.; Wong,VWS.; Suen,BJ. (Lancet, 2007)